Clinical Trials Underway for New GLP-1 Agonist Retatrutide | Retatrutide News

Retatrutide, a new GLP-1 agonist, is in clinical trials and may offer stronger effects than current options. Eli Lilly is developing this drug as part o...
Clinical Trials · October 24, 2026